A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part II
- 1 January 1997
- journal article
- review article
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 4 (1) , 52-60
- https://doi.org/10.1016/s1071-3581(97)90049-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Gender-related differences in clinical management after exercise nuclear testingJournal of the American College of Cardiology, 1995
- Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial InfarctionNew England Journal of Medicine, 1995
- The Journal's Policy on Cost-Effectiveness AnalysesNew England Journal of Medicine, 1994
- Economics of elective coronary revascularizationJournal of the American College of Cardiology, 1993
- Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiographyJournal of the American College of Cardiology, 1993
- Clinical economics. A guide to the economic analysis of clinical practicesJAMA, 1989
- Comparative costs of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in multivessel coronary artery diseaseThe American Journal of Cardiology, 1988
- Confronting publication bias: A cohort design for meta‐analysisStatistics in Medicine, 1987
- Use and Misuse of the Term “Cost Effective” in MedicineNew England Journal of Medicine, 1986
- Comparative cost of myocardial revascularization: Percutaneous transluminal angioplasty and coronary artery bypass surgeryJournal of the American College of Cardiology, 1985